PI3K/mTOR Inhibitor-2 NEW
| Price | $53 | $148 | $238 |
| Package | 1mg | 5mg | 10mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2026-01-05 |
Product Details
| Product Name: PI3K/mTOR Inhibitor-2 | CAS No.: 1848242-58-9 |
| Purity: 99.54% | Supply Ability: 10g |
| Release date: 2026/01/05 |
Product Introduction
Bioactivity
| Name | PI3K/mTOR Inhibitor-2 |
| Description | PI3K/mTOR Inhibitor-2 is a potent pan inhibitor of PI3K and mTOR with IC50s of 3.4, 34, 16.1, and 4.7 nM for PI3Kα, PI3Kβ, PI3Kδ, PI3Kγ, and mTOR, respectively. PI3K/mTOR Inhibitor-2 demonstrates antitumor activity. |
| In vitro | PI3K/mTOR Inhibitor-2 exhibited high enzyme activity against PI3K and mTOR, potent suppression of Akt and p70s6k phosphorylation with IC50s of 11.6 and 89.2 nM in cell assays, and good pharmacokinetic profile[1]. |
| In vivo | PI3K/mTOR Inhibitor-2 demonstrated in vivo efficacy in a PC-3M tumor xenograft model[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 55 mg/mL (114.86 mM), Sonication is recommended. |
| Keywords | PI3Kδ | PI3Kγ | PI3Kβ | PI3Kα | PI3K/mTOR Inhibitor-2 | PI-3K/mTOR Inhibitor-2 | PI3K/mTOR Inhibitor2 | PI3K/mTOR Inhibitor 2 | PI3K | Phosphoinositide 3-kinase | mTOR | Mammalian target of Rapamycin | Inhibitor | inhibit |
| Inhibitors Related | Musk ketone | Stearamide | Myricetin | Creatine monohydrate | Hyaluronic acid | 4-Methylbenzylidene camphor | N-Hydroxyphthalimide | L-Proline | Isoprenaline hydrochloride | Methyl eugenol | Metformin hydrochloride | Dihydromyricetin |
| Related Compound Libraries | Anti-Lung Cancer Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Autophagy Compound Library | Anti-Cancer Metabolism Compound Library | Inhibitor Library | Anti-Prostate Cancer Compound Library | Immunology/Inflammation Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1520.00/25mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-01-05 | |
| $2780.00/50mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-01-05 | |
| $2.00/100kg |
VIP1Y
|
ZHENGZHOU JIUYI TIME NEW MATERIALS CO,.LTD
|
2025-06-24 | |
| $53.00/1mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-01-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY